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Research Article Review 
Submitted by Jean Beckel, RN, MPH 
 
Article: Barr-Anderson, D., van den Berg, P., Neumark-Sztainer, D., Story, M. (2008). 
Characteristics Associated with Older Adolescents Who Have a Television in Their 
Bedrooms. Pediatrics. 121(4). 718-724. 
 
As we approach the dark days of winter, there is increased temptation to 
spend time in front of the TV. As a parent, I have had the “TV in the 
bedroom” discussion with kids. The focus of this study, completed at the U of 
MN, was to examine the prevalence of adolescents having a TV in their bedroom, and to describe the 
associated personal, social, and behavioral characteristics. The literature review solidly documented 
the TV-watching habits of the American teenager and indicated an association between the amount of 
TV watching and poor school performance, poor dietary habits, and greater basal metabolic index. It 
also found that youth who have a TV in the bedroom watch more hours per day of television. The 
literature was lacking information related to the adolescent profiles for those having bedroom TVs. 
 
The researchers built on a prior research study which had tracked the behaviors and eating habits of 
4,746 junior and senior high school students in 31 Minnesota schools. The new study involved 781 of 
these students who met the age criteria for the new study. Participants completed a revised version of 
the original study survey which asked about presence of a bedroom TV and their physical activity and 
social behavior. 62% of the adolescents had a TV in their bedroom. Statistical analysis was used to 
compare the teens with and without TVs in their bedroom. The presence of a TV was related to 
gender, ethnicity and socio-economic status. Those with a bedroom TV also spent less time in vigorous 
physical activity, eating fruits and vegetables, and having family meals together. There was also more 
sedentary behavior and lower GPAs. There was no difference between snacking habits between 
groups. Those with a TV also reported a much higher number of TV viewing hours. 
 
Limitations of this study include the design where measurements were taken as a moment in time. 
Researchers also relied on the accuracy of the adolescents’ self-reported responses to the study 
questionnaire to make their conclusions. The strengths of the study include the large, ethnically 
diverse study sample and the design of the survey tool. What are the conclusions?  
• As a parent: Many parents now work outside the home and have less control over the 
number of hours their children watch TV. Parents do, however, make the decision on 
whether or not a child can have a TV in their bedroom. Making a decision to refrain 
from a bedroom TV may be the first step to decreasing “screen time” and the poor 
behaviors associated with increased TV watching.  
• As a nurse: What aspects of our professional practice environment could be measured 
and analyzed to result in better use of our time, space, and energy?  
 
If you have ideas, please contact a member of the research committee. This group will guide you and 
make the research process a practical and fun experience.  
St. Cloud Hospital, 1406 6th
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Providing Care After Death – Important Steps to Follow: 
Submitted by Barb Scheiber, Director, Patient Care Support 
 
There are many steps to follow when a patient dies. The death checklist and policy, “Death, Care 
Provided After” are resources for you. We continue to have some issues with Funeral Home Directors 
arriving to pick up a body when donation status, autopsy, etc. are still pending. Please coordinate the 
release of the body with the PPC/Administrative Nursing Supervisor for each death. Below are a few 
reminders: 
• The death checklist serves as your guide. It follows in order of priority. For example, if a death is 
unexpected or unexplained, you need to sequester equipment and have blood drawn as soon as 
possible. Therefore, this item is listed at the top of the list. 
• The Administrative Nursing Supervisor/Patient Placement Coordinator must be notified of each 
death. Include the name, time of death, medical record number, funeral home/location if known, 
and any pending reasons for delaying the release of the body to the funeral home (example: ME 
case, autopsy, organ/tissue/eye donation). Once everything has been completed, the 
Administrative Nursing Supervisor/Patient Placement Coordinator notifies Admitting and authorizes 
the release of the body to the funeral home. Admitting then calls the funeral 
home to pick up the body. 
• Admitting should be called with the name, medical record number and time of 
death as soon as possible. They maintain a log book of all deaths and are the 
access point for funeral directors who pick up bodies. Funeral directors “sign 
out” when they leave. 
• At times family members have told the funeral home that “everything is done.” 
Unfortunately this can result in the funeral home director driving a distance only 
to learn that some things are still pending (example: tissue donation). It would be helpful if you 
could let family members know that the hospital (Admitting) will notify the funeral home once 
everything is complete. 
• An order for release of the body needs to be entered into EPIC. 
 
Finally, “thank you” for your compassion and sensitivity in the care of the deceased. Families always 
remember those final moments and the caring manner of staff after death. It is a lasting impression 
and a testimony of our mission and values. 
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Anticoagulation Management Program Implementation  
Debra Miller, Pharm.D., Medication Safety Pharmacist 
 
The Joint Commission has introduced a new National Patient Safety Goal to reduce the likelihood of 
patient harm from therapeutic anticoagulation with Heparin, Warfarin and Low Molecular Weight 
Heparin.  The program intent is to individualize anticoagulation therapy for each patient through use 
of standardized evidence-based practices specifically designed to reduce the risk of adverse drug 
events.  
 
The goal includes the following eleven requirements, with the expectation that, as of January 1, 2009, 
the process is fully implemented across the organization.  Please review the following list of 
policies/protocols that were updated to meet the new requirements: 
1. The organization must implement a defined anticoagulant management program to 
individualize the care provided to each patient receiving anticoagulant therapy.  See: 
• Warfarin General Dosing and Reversal Guidelines  
• Warfarin Anticoagulation Ordering Policy 
• Heparin and Low Molecular Weight Heparin (LMWH) Including Enoxaparin (Lovenox) 
Anticoagulation Ordering Policy 
• Anticoagulant Therapy:  Management and Monitoring in the Home Setting 
2. The organization uses approved protocols for the initiation and maintenance of anticoagulation 
therapy appropriate to the medication used, to the condition being treated, and to the 
potential for drug interactions.  See: 
• Heparin Weight Based Protocol 
• St. Cloud Hospital Clinical Pharmacy Warfarin Dosing Service Protocol: 
To order a pharmacist consult for dosing warfarin, prescribers should place a “Pharmacy to 
Dose Warfarin Consult” in EPIC and state the desired INR goal range.  Pharmacists use 
evidence-based Warfarin General Dosing and Reversal Guidelines within a protocol that was 
approved by the Pharmacy and Therapeutics Committee.  Daily INR will be ordered by the 
pharmacist per protocol (if not already ordered) for all inpatients.  For patients in Inpatient 
Rehab and Adult Mental Health who are stabilized on warfarin therapy, the frequency of INR 
may be decreased to every 3 days.  The physician will be contacted anytime the INR is greater 
than 5.0 and/or signs of significant bleeding are reported, for reversal strategy.   
• Adult Renal Dosing Protocol (see Lovenox) 
• Anticoagulant Therapy:  Heparin/Low Molecular Weight Heparin (LMWH), Coumadin Policy 
• Drug/Drug Interaction Policy 
3. To reduce compounding and labeling errors, the organization uses ONLY oral unit dose 
products and pre-mixed infusions, when these products are available. 
• Provided by Pharmacy 
4. When pharmacy services are provided by the organization warfarin is dispensed for each 
patient in accordance with established monitoring procedures.  See: 
• St. Cloud Hospital Clinical Pharmacy Warfarin Dosing Service Protocol  
• Warfarin Anticoagulation Ordering Policy 
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5. For patients being started on warfarin, a baseline International Normalized Ratio (INR) is 
available, and for all patients receiving warfarin therapy, a current INR is available and is used 
to monitor and adjust therapy.  See: 
• Warfarin Anticoagulation Ordering Policy 
6. When dietary services are provided by the organization, the service is notified of all patients 
receiving warfarin and responds according to its established food/drug interaction program.  
See: 
• Drug/Food Interaction Counseling Policy 
• Drug/Food Interaction Counseling, Appendix B, Identified Drugs: 
Dietitians are automatically notified via the Epic of each initial warfarin order and do not 
require the nurse to place a dietitian consult.  Dietitians will complete food and drug 
interaction education for all patients who are new to warfarin.  Warfarin education consults DO 
NOT automatically need to be placed by the nursing staff.  However, for those patients 
previously taking warfarin prior to admission that still have concerns related to warfarin and 
Vitamin K intake, nursing may then place a dietitian consult as needed.  Food Services is also 
notified daily of all patients currently receiving warfarin for review of menu items for 
appropriateness. 
7. When heparin is administered intravenously and continuously, the organization uses 
programmable infusion pumps.  See: 
• Medication Administration Policy, High Alert Medications, Addendum B  
8. The organization has a policy that addresses baseline and ongoing laboratory tests that are 
required for heparin and low molecular weight heparin therapies.  
• Heparin and Low Molecular Weight Heparin (Lovenox) Anticoagulation Ordering Policy (new 
policy):   
• The Pharmacy and Therapeutics Committee approved a new Heparin and Low Molecular Weight 
Heparin (Lovenox) Anticoagulation Ordering Policy which may be viewed on Centranet.  The 
policy describes standards of practice and procedures for dosing and monitoring of 
Heparin/LMWH that is similar to the Warfarin Anticoagulation Ordering Policy that was 
approved in March.  Some of this information is summarized here.  Platelet monitoring is 
suggested for patients receiving prophylactic subcutaneous heparin at baseline and every two 
days on days 4-14 to monitor for heparin induced thrombocytopenia.  For Lovenox, platelet 
counts are suggested at baseline and every three days on days 4-14.  When therapeutic 
anticoagulation doses of Lovenox are used at 1 to 1.5 mg/kg in obese patients the maximum 
dose will be capped at 150 mg/dose.  Anti-Xa monitoring may be used to guide therapy and 
pharmacists will consult physicians regarding ordering of these.  For patients with renal 
dysfunction at < 30 ml/min, a continuous infusion of Heparin should be used instead of 
Lovenox. 
9. The organization provides education regarding anticoagulation therapy to prescribers, staff, 
patients, and families.   
• Nurses and Dieticians:  Medication Safety – Anticoagulation and High Alert Medications 
computerized module. 
• Pharmacists:  Warfarin, Heparin, Lovenox and High Alert Drugs computerized module and SCH 
Clinical Pharmacy Warfarin Dosing Service Competency Exam. 
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• Prescribers:  “Anticoagulation Management Program” article in Medical Staff Update December 
2008 issue, and “Warfarin General Dosing and Reversal Guidelines” pocket card available in 
Medical Staff Office. 
• Patients/families:  Every patient in the hospital is required to receive a standard approved 
anticoagulation teaching sheet, even those patients who have had this education in the past 
(see instructions on accessing these below). 
10. Patient/family education includes the importance of follow-up monitoring, compliance issues, 
dietary restrictions, and potential for adverse drug reactions and interactions.  
Accessing SCH approved standard patient/family education: 
• Warfarin Education Sheet:  St. Cloud Hospital has identified a standard teaching sheet for 
warfarin, and it is available through Order Entry in Epic.  The PMI/DFIs from Micromedex and 
McKesson are not approved for patient education of warfarin.  To print the teaching sheet 
through Order Entry in Epic type:  “Optio – Warfarin” in the search box.  Select OPTIO-CMHC 
COUMADIN (WARFARIN) EDUCATION SHEET.  Review the education sheet with the patient and 
document education teaching point into EPIC. 
• Enoxaparin (Lovenox) Teaching Kit:  The standard patient education teaching sheet identified 
for Lovenox is available through the Distribution Center.  Order teaching kit through Order 
Entry in Epic by typing “LOVENOX” in the search box, then select “KIT LOVENOX PATIENT 
EDUCATION”.  Review information with patient and document education teaching point into 
Epic.   
• Heparin Education Sheet:  The standard patient education teaching sheet identified for 
heparin is available in MICROMEDEX CareNotesTM System.  Print Heparin (injection) teaching 
sheet, review with patient, and document education teaching point into EPIC. 
Documentation of patient teaching into Epic (Warfarin Example): 
Every patient in the hospital is required to receive an anticoagulation teaching sheet, even those 
patients who have had this education in the past and the teaching point must be documented into 
Epic: 
1. Enter Patient Education activity. 
2. Select “Add Point” from the Unresolved Education tab. 
3. Search for “coumadin” and select COUMADIN POINT to add to unresolved education list. 
11. The organization evaluates anticoagulation safety practices. 
• Oversight of this requirement is through Medication Safety, Pharmacy and Therapeutics, 
Medical Care Review, and Advanced Nurse Practice – PI Committees. 
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Chart is based on goal INR range of 2.0-3.0.
Charts adapted with permission from Mercy and Unity Hospital 
Warfarin Dosing Service and from ACCP Evidence-Based Clinical 
Practice Guidelines 8
th 
Edn. CHEST.  June 2008:  133(6Suppl): 
160S-198S.  
DAY  INR  Warfarin Dose for < 
80kg  
Warfarin Dose for > 
80kg  
CLINICAL 
PICTURE  INR  RECOMMENDATION  
Above  No significant  -Decrease dose or omit  1  < 1.5  5 mg (2.5 mg if age > 
60)  
7.5 mg  (5 mg if age > 
60)  goal  bleeding  warfarin dose and resume  
 2  < 1.8  5 mg (see previous 
dose)  
7.5 mg (see previous 
dose)  
when INR therapeutic  range  
  but < 5.0  
 1.92.5  2.5-5 mg  2.5-5 mg  5.0 – 8.9  No significant 
bleeding  
-Omit warfarin x 1-2 doses -
OR--Omit warfarin dose and 
give Vitamin K 1-2.5 mg PO   2.63.0  0-2.5 mg  0-2.5 mg  
 > 3.0  NONE  NONE  5.0 – 8.9  Rapid reversal 
needed for surgery  
-Omit warfarin -AND--
Vitamin K 1-5 mg PO with  
expectation for reduction in 
INR in 24 hrs (may repeat 12 
mg PO if needed)  
3  < 1.8  5 mg  7.5 mg  
 1.92.5  2.5-5 mg  2.5 mg  
 2.63.0  0-2.5 mg  (see 
previous dose)  
0-2.5 mg (see previous 
dose)  
> 9.0  No significant 
bleeding  
-Omit warfarin -AND--
Vitamin K 2.5 -5 mg PO 
(may repeat in 24 hrs if 
needed)  
 > 3.0  NONE  NONE  
4  < 1.5  10 mg  10-15 mg  
 1.51.9  5-7.5 mg  5-10 mg  






of INR  
Serious bleeding  -Omit warfarin -AND--
Vitamin K 10 mg slow IV 
(may repeat q12 hrs if 
needed) -May supplement 
with fresh frozen plasma 
(FFP), prothrombin complex 
concentrates (PCC), or 
recombinant factor VIIa 
depending on the urgency of 
the situation  
 > 3.0  0-2.5 mg  0-2.5 mg  
5  < 1.5  10 mg  10-15 mg  
 1.51.9  7.5-10 mg  5-10 mg  




 > 3.0  0-2.5 mg  0-2.5 mg  
6  < 1.5  7.5-12.5 mg  15 mg  
 1.51.9  5-10 mg  5-12.5 mg  
Any 
elevation 
of INR  
Life-threatening 
bleeding  
-Omit warfarin -AND--Fresh 
frozen plasma (FFP), 
prothrombin complex 
concentrates (PCC), or 
recombinant factor VIIa -
Supplement with vitamin K 
10 mg slow IV (may repeat 
q12 hrs if needed)  




 > 3.0  0-5 mg (depending 
on previous dose)  
0-5 mg (depending on 
previous dose)  
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~Clinical Ladder~ 
Congratulations to the following individuals for achieving 
and/or maintaining their Level III Clinical Ladder status! 
 
 
Ann Hess, RN Ortho/Neuro
Patient Care News articles should be sent to Deb Kaufman in Patient Care Support by the 25th of each month. 
 Angela Jordahl, RN Kidney Dialysis 
 Osteoporosis and You Class  PI Committee, PI Audits 
 Dressing Change Audit  Fistula First Task Force 
 Patient Education Committee  Button-Hole Certification with Staff 
 EPIC Super User  Research Study to Present Hypotension During 
Dialysis  
 Nancy Stiles, RN Emergency Trauma Center 
 Preceptor Gayle Howard, RN Ortho/Neuro 
 Clinical Ladder Secretary  Med Safety Event 
 EBP: Sudden Death Notification  Preceptor 
 Medication Safety Task Force  Total Joint Class Instructor 
 ONC  
 Carla Vanderpool, RN Children’s Center 
 Airway Cart Set-up  
 Preceptor Upcoming Developmental Programs: 
Educational and Professional  Easy IO Poster  Patient Satisfaction Committee 
  
February 2009Janelle Maciej, RN Telemetry  
 Upcoming Cardiac Medications Module 6 Basic Life Support Instructor Recertification 
Course, Conference Center, 9 am-1 pm  Preceptor 
 Biphasic Defibrillators Old/New Stations 
9/10 Nursing Professional Development Cert. 
Preparation Course, 7:30 am-4:30 pm, 
Windfeldt Room, CentraCare Health Plaza 
 Clinical Ladder Committee 
 
Amy Anderson, RN Kidney Dialysis, Alexandria 
 PI Committee, PI Audits 24 Sugar & Safe Care, Temp., Airway, Blood 
Pressure, Lab Work, and Emotional Support 
(STABLE), 7 am-5:30 pm, CentraCare Health 
Plaza Education Center 
 Holistic Services DVD 
 ANNA Education Committee Member 
 Fistula First Committee  
 26 10th Annual Cardiology Seminar, 7:30 am-4 
pm, Windfeldt Room, Plaza Cindy Emerson, RN Peds Short Stay 
 Port Access Skill Station 
March 2009 Patient Safety Monitoring Audit  
 Peds Hem/Onc Advisory Board  2  Basic Life Support Instructor Initial 
Course, Conference Center, 9 am-5 pm  RNC, Pediatric 
 
24/25 Trauma Nursing Core Course (TNCC), 7:30 
am-5:30 pm, SCH Conference Room 
Nicole Witowski, RN PICU 
 Preceptor 
 Instilling NS with Suctioning Poster 30/31 Emergency Nursing Pediatric Course/ENPC, 
8 am-5:30 pm, SCH Conference Room  Safeway Reporting Committee 
  AACN-CMAC Secretary 
 To find out what other educational and 
professional developmental programs  Colleen Layne, RN Center for Surgical Care 
 Outpatient FHA are offered, please go to the CentraNet 
Education Tab or call the Education 
Department at Ext. 55642 
 PI Committee, PI Audits 
 Chair, Engagement Task Force 
 RNC, Med/Surg  
 
